July 30th, 2019

MBio Diagnostics featured in the Denver Business Journal, "How a Colorado biotech company aims to do what Theranos couldn't"

August 4th-8th, 2019

MBio Diagnostics will be exhibiting at AACC in Anaheim, CA. Booth 2380. 

August 15th, 2019

MBio Diagnostics will be hosting the CPIA Quarterly Meeting at the MBio facility in Boulder, CO, register to attend here

August 20th, 2019

Chris Myatt will be leading a panel discussion on, "Current Trends in the Veterinary Dx Space" at the Next Generation Dx Summit in Washington, DC 

August 21st, 2019

Chris Myatt will be leading a short course on, "Microfluidics and Lab-on-a-Chip Devices for POCT: Technologies and Commercialization" at the Next Generation Dx Summit in Washington, DC 


Press Releases

MBio Diagnostics, Inc. Announces Two Contracts for Sepsis Test Development 

August 1st, 2019

Brava Diagnostics Announces Exclusive License Agreement and Collaboration with MBio Diagnostics for Point-of-Care Tests

January 3rd, 2019

MBio Diagnostics, Inc. Announces Additional $6 Million in Series B Funding

August 21, 2018

MBio Announces License and Development Partnership with Heska

May 15, 2018

DARPA Awards MBio Phase II Contract for Acute Infection Point-of-Care-System

February 14, 2018

MBio Diagnostics Expands IP Portfolio - Announces Issuance of Two New Patents
January 4, 2018